Universe Pharmaceuticals Inc
2 hedge funds and large institutions have $2.38K invested in Universe Pharmaceuticals Inc in 2024 Q1 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 1 reducing their positions, and 0 closing their positions.
100% more funds holding
Funds holding: 1 → 2 (+1)
0% less ownership
Funds ownership: 0% → 0% (-0%)
80% less capital invested
Capital invested by funds: $12K → $2.38K (-$9.62K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$2.26K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Acadian Asset Management
Boston,
Massachusetts
|
-$11.3K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
UBS Group
Zurich,
Switzerland
| $2.38K | +$2.26K | +2 | New |
|
|
2
Acadian Asset Management
Boston,
Massachusetts
| – | -$11.3K | -10 | -91% |
|
UPC Hedge Fund Activity: Q1 2024 in Review
2 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in Universe Pharmaceuticals Inc (UPC) for Q1 2024, worth a combined $2.38K — down 80% from $12K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new UPC positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 1 trimmed.
The largest buyer was UBS Group, opening a new position worth an estimated $2.26K. The largest seller was Acadian Asset Management, cutting an estimated $11.3K.
- 2 institutional investors held Universe Pharmaceuticals Inc (UPC) as of Q1 2024, up from 1 in Q4 2023.
- Funds reported $2.38K of Universe Pharmaceuticals Inc stock for Q1 2024, down 80% quarter-over-quarter.
- 1 fund opened new Universe Pharmaceuticals Inc positions in Q1 2024 and 0 closed out, a net change of +1 holder.
- The largest Universe Pharmaceuticals Inc buyer in Q1 2024 was UBS Group, an estimated $2.26K added.
- The largest Universe Pharmaceuticals Inc seller in Q1 2024 was Acadian Asset Management, an estimated $11.3K sold.
Based on aggregated 13F filings for Q1 2024.